INDIAN multinational pharmaceutical company Alembic Pharmaceuticals on Thursday (23) said it has received final nod from the US health regulator for fenofibrate tablets, which reduces cholesterol and triglycerides in blood.
"Alembic Pharmaceuticals Limited (Alembic)...has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fenofibrate Tablets USP, 54 mg and 160 mg.
"The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Tricor Tablets, 54 mg and 160 mg, of AbbVie Inc (AbbVie)," the drug firm said in an exchange filing.
Fenofibrate tablets have an estimated market size of $100 million for twelve months ending September 2019, according to IQVIA.
"Fenofibrate tablets are indicated as an adjunct to diet to reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidaemia and for treatment of adult patients with severe hypertriglyceridemia," it said.
Alembic has a cumulative total of 113 ANDA approvals 100 final approvals and 13 tentative approvals from the USFDA.
Camila Cabello signalled her team for help as she continued dancing with fans cheering her onInstagram/
Camila Cabello's pale pink corset and matching skirt were styled by designer Heather PicchiottinoInstagram/
Cabello later joked about the wardrobe mishap with a playful selfie on InstagramInstagram Screengrab/
Prince Harry and Meghan Markle are reportedly working on a Netflix documentary about Princess Diana for 2027Getty Images 
Prince Harry and Meghan Markle's renewed deal with Netflix could see them sharing Diana’s story with global audiencesGetty Images 
Princess Diana’s legacy remains central to Prince Harry and Meghan Markle’s upcoming Netflix projectsGetty Images
Meghan’s lifestyle series With Love, Meghan returns alongside talks of a Diana documentaryGetty Images
Princess Diana, Prince Harry and Prince William gather for the commemorations of VJ DayGetty Images